Rita
Suri
Moderator
Montreal, QC
Dr. Rita Suri
Dr. Suri is a nephrologist, Associate Professor, and Director of the Division of Nephrology at McGill University. She is actively engaged in clinical practice, teaching, and research, and is nationally recognized for her leadership in research, network development, and teaching. Dr. Suri is a CIHR-funded clinical researcher and FRQS Junior 2 research scholar with > 70 publications and 5 book chapters. Her research interests are in clinical trials of dialysis, dialysis prescription, and adequacy of dialysis.
She has served on multiple Guidelines Committees for the CSN, KDOQI, and KDIGO. She is also a Scientific Officer for the CIHR Randomized Controlled Trials panel and the Kidney Foundation Grants Committee, and a member of the CIHR Advisory Board for the Institute of Circulatory and Respiratory Health. Dr. Suri is an active member of the Canadian Society of Nephrology. She has served on the Board of Directors as a Member at Large for Quebec, participated in several program planning initiatives and committees for the Society, including the World Congress of Nephrology local organizing committee, and delivered many lectures at the CSN pre-course. Her other accomplishments include being Chair and founder of the Canadian Nephrology Trials Network.
S. Joseph
Kim
Speaker: PRO
Toronto, ON
Dr. Joseph Kim
Dr. Joseph Kim is a staff nephrologist in the Division of Nephrology and Director of the Kidney Transplant Program at the Toronto General Hospital, University Health Network. He is also an Associate Professor in the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is the Vice Chair of the Medical Advisory Committee at the University Health Network, Chair of the Data System Working Group for the Organ Donation and Transplantation Collaborative at Health Canada, Chair of the Global Data Harmonization Committee for the Transplantation Society, and Past-President of the Canadian Society of Transplantation.
Dr. Kim completed medical school, internal medicine residency, and fellowships in nephrology and kidney transplantation at the University of Toronto. In 2008, he earned a PhD in epidemiology and a Master of Health Science in biostatistics at the Johns Hopkins Bloomberg School of Public Health. In 2020, he completed a Global Executive MBA for Healthcare and the Life Sciences at the Rotman School of Management, University of Toronto. Dr. Kim’s research interests include access to and outcomes of kidney transplantation as well as using data more effectively to inform health system improvement.
John
Gill
Speaker: CON
Vancouver, BC
John Gill
MD, MS, FRCPC
Fellow of American Society of Transplantation
John Gill is Professor of Medicine with Tenure at the University of British Columbia, Division of Nephrology, Saint Paul’s Hospital.
John completed his medical training in 2000 (BSc. 1990 UBC, MD 1995 UBC, Internal Medicine 1998 Western University, Nephrology 2000 UBC) and completed a Master’s Degree in clinical care research at Tufts University, Boston (2002) before joining the Division of Nephrology at UBC in July, 2002 with a cross appointment in the Centre for Health Evaluation and Outcomes Sciences (CHEOS).
John is a past president of the American Society of Transplantation, Consulting Editor of the American Journal of Transplantation, Associate Editor of the Journal of the American Society and Member of the Declaration of Istanbul Custodial Group. He has served as Chair of the Scientific Registry of Transplant Recipients Visiting Committee, Executive of the Kidney Disease Improving Global Outcomes, and member of the United States Renal Data System external expert advisory panel. He has served as an external advisor on a number of NIH studies in transplantation.
John has served as Past President of the Canadian Organ Replacement Register and Past President of the Canadian Society of Nephrology. He is a past member of the Royal College of Physicians and Surgeons Ethics Committee and is a member of the Canadian Blood Services Kidney Transplant Advisory Committee.
John is an active researcher whose diverse interests include clinical outcomes in kidney transplantation, access to care, clinical trials, health services research and research ethics. He is recipient of the American Society of Transplantation Established Clinical Investigator Award and the American Association of Kidney Patients Medal of Excellence. Relevant to this presentation he is principal investigator of the CARSK trial.